Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    Czechia Denmark France Germany Greece Italy +3
  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia Denmark Finland France Germany +4
  • A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Croatia Czechia Denmark France +6
  • A study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Spain
  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Hungary
  • Testing Cabozantinib Dose Skipping Schedule Compared to Dose Reduction in Patients with Kidney Cancer Taking Cabozantinib Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Evaluating kidney cancer aggressiveness using Rubidium Chloride PET scan imaging in patients with renal cell carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of XL092 and belzutifan combination therapy in people with clear cell kidney cancer who had disease return during or after immunotherapy treatment

    Recruiting

    1 1 1
    France Poland Spain
  • Study on Digital Monitoring of Symptoms in Patients with Advanced Kidney Cancer Treated with Cabozantinib and Nivolumab

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands